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Abstract
Heart failure (HF) is a serious, chronic, and progressive condition which may require hospitalization if decompensated. Each
year, in the UnitedStates, there are approximately 1 million hospitalizations due to decompensated HF at a cost of $39 billion.
Because limited information examining the association between gender and length of stay (LOS) is available in the published
literature for Puerto Ricans hospitalized with decompensated HF, we aim to investigate gender differences related to LOS in this
population.
This study is a secondary data analysis of the Puerto Rico Cardiovascular Disease Surveillance System database, which is a
nonconcurrent prospective study carried out in 2007 and 2009. LOS was dichotomized into 5 days or ≥6 days (extended)
categories. The x2 test was used to examine associations between categorical variables. Binary logistic regression was used to
estimate unadjusted and adjusted odds ratios of extended LOS. Collinearity was assessed using Pearson correlation coefﬁcients. A
P value of 0.05 and 95% conﬁdence intervals were used to evaluate statistical signiﬁcance.
A total of 1724 patients (47.6% women) comprised our study population. The average age of women was 72.5±13.4 years; the
average age of menwas 67.2±14.5 years. For both women andmen, median LOSwas 5 days (interquartile range=5 days). Women
were more likely than men to have diabetes mellitus, hypertension, and dyslipidemia, but current smoking was higher in men than in
women. The proportion of patients with extended LOS was similar for men (43.3%) and women (45.1%) (P=0.448). Likewise, the
odds for extended LOS was comparable for both genders (OR=1.1, 95% CI=0.9, 1.4). Patients admitted with recurrent
decompensated HF hospitalizations had shorter LOS than patients with initial episodes (OR=0.7, 95% CI=0.6, 0.9). However,
factors that prolonged the LOS included the presence of renal failure (OR=1.7; 95% IC=1.3, 2.1) and ejection fraction (EF) <35%
(OR 0.7; 95% CI 0.6, 0.9).
Althoughwewere not able to ﬁnd statistically signiﬁcant association between LOS and gender in Puerto Rican patients hospitalized
with decompensated HF our ﬁndings suggest that incidental episodes and having an EF<35% increase the odds of extended LOS.
Abbreviations: EF = ejection fraction, HF = heart failure, ICD-9-CM = International Classiﬁcation of Diseases-Ninth Revision-
Clinical Modiﬁcation, LOS = length of stay, MI =myocardial infarction, PRCVSS = Puerto Rico Cardiovascular Disease Surveillance
System.
Keywords: gender, heart failure, Hispanic, hospitalization, length of stay, Puerto Rico
1. Introduction
Heart failure (HF) is “a clinical syndrome resulting from the
heart’s inability to meet the body’s circulatory demands under
normal physiological conditions.”[1] HF is one of the leading
causes of morbidity and mortality worldwide with an estimated
prevalence of over 23 million cases.[2] In the United States, the
number of HF cases is estimated to be close to 6 million.[2–3]
Further, the 5-year mortality rates among HF patients almost
rival those of cancer patients.[2] Overall hospital care constitutes
a third of all health care expenditures in the United States, and
represent a signiﬁcant impact to the US economy.[4] The speciﬁc
number of hospitalizations for decompensated HF in the United
States has increased dramatically in the past decade with
approximately 1 million annual hospitalizations occurring
during recent years, and a total cost that exceeds $39 billion
per year.[2,5] This particular situation represents a major burden
for the entire US health care system.[2,5–7] On the contrary, the
average length of stay (LOS) in hospitals is a statistical calculation
often considered as a universal metric for gauging the success of
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hospital cost containment, cost reduction, and alternative care
delivery systems.[8] Improving hospital care efﬁciency by
reducing the LOS should beneﬁt both patients and hospitals.
Unnecessary hospital stays expose patients to potential iatrogenic
infections and increased costs, whereas enforcing uniform
evidence-based standards may enhance health care services
and reduce the days of hospitalization. The need to further study
the effects of the use of LOS in speciﬁc conditions with standard
methods in order to achieve homogenous and comparable results
has been recommended by the World Health Organization.[8]
Thus, the LOSmay be a proxy of adequate management care and
prognosis of patients hospitalized with a decompensated HF.[9]
Although many articles have reviewed potential factors inﬂuenc-
ing LOS in patients with decompensated HF, there is limited
published information in the scientiﬁc literature on the associa-
tion between gender and extended LOS among Hispanic patients
with HF. The objective of this study is to investigate gender
differences related to LOS in Puerto Ricans (a mostly Hispanic
population) hospitalized with decompensated HF during study
years 2007 and 2009.
2. Methods
The Puerto Rico Cardiovascular Disease Surveillance System
(PRCVSS) was a nonconcurrent prospective study carried out in
2007 and 2009. The current study is a secondary data analysis of
the PRCVSS database intended to ascertain any association
between gender and extended LOS. PRCVSS investigators
reviewed the medical records of Puerto Rican patients hospital-
ized for possible decompensated HF at 21 academic and/or
nonteaching medical, as well as nonmilitary, centers with
emergency room capability. According to the United States
Bureau Census, the Puerto Rican population is considered mostly
Hispanic and in 2010 there were 3,700,000 individuals residing
on the Island.[10] A complete listing with information on all
hospital discharges during study years 2007 and 2009 with
International Classiﬁcation of Diseases, Ninth Revision, Clinical
Modiﬁcation (ICD-9-CM) codes 428.0 to 428.9 in the principal
and/or secondary diagnosis position was obtained from each of
the participating hospitals. Once the computerized discharge
diagnosis printouts were obtained from each participating
hospital, the appropriate ICD-9-CM codes for HF were reviewed
for purposes of case validation. The list of selected medical
records to be reviewed was given to medical record department
personnel at each participating hospital. Trained nurse and
physician abstractors reviewed the medical records of all
identiﬁed patients meeting the clinical criteria for HF: presence
of dyspnea/shortness of breath, fatigue, and at least one
diagnostic imaging report of systolic or diastolic dysfunction
and ejection fraction (EF) using echocardiogram, multigated
acquisition scan, computerized axial tomography scan, cardiac
catheterization, or nuclear stress test.[11]
For the current study, the original sample size comprised 1818
patients with ICD-9-CM codes 428.0 to 428.9. We excluded
patients below 18 years old, patients with missing information on
the number of days in the hospital, negative LOS values due to
ﬁtful dates of admission and discharge, those with reported LOS
less than 1 day or over 30 days, patients who developed HF
during cardiac invasive procedure such as percutaneous coronary
interventions or coronary bypass surgery, or those who
developed HF secondary to another acute disease.
The outcome variable was LOS, dichotomized based on the
median length of stay, which was 5 days, into5 days or ≥6 days
(extendedLOS).Genderwas themainexposureof interest. Possible
confounders included age and risk factors for HF such as diabetes
mellitus, hypertension, dyslipidemia, smoking, history of myocar-
dial infarction (MI), history of a prior HF hospitalization, and EF
less than 35%. Age was categorized as follows: less than 50 years,
50 to 65, and 66 years or older. Risk factors were dichotomous
variables coded as present or not present. Renal failure was
included as a risk factor for prolonged LOS.[7] Smoking status was
dichotomous and was deﬁned by current smoking status.
2.1. Statistical methods
The x2 test was used to determine the association between
categorical variables. Binary logistic regression was used to
estimate unadjusted and adjusted odds ratios. Factors conserva-
tively associated with both gender and LOS (P0.2) were
included in the adjusted model. Risk factors that didn’t meet the
statistical criteria were included if they were determined to be
clinically signiﬁcant. Collinearity was assessed using Pearson
correlation coefﬁcients. P-values of 0.05 and 95% conﬁdence
intervals were used to assess statistical signiﬁcance. SPSS, IBM,
Armonk, New York Statistical Software version 22 (IBM) was
utilized for all statistical analysis. Ethical approval was waived
since the analysis was considered nonhuman subjects research by
the Florida International University Health Science IRB.
3. Results
The ﬁnal sample size was 1724 patients (47.6% women). The
average age of women was 72.5±13.4 years and the average age
Table 1
Characteristics of Puerto Ricans hospitalized with decompen-
sated heart failure (HF) (N=1724).
Gender
Characteristics Men (n=904) Women (n=820) P
Age <0.001
<50 11.1 % 5.9%
50–65 32.2 % 21.6%
≥66 56.7 % 72.6%
Diabetes mellitus 0.09
Yes 57.7% 61.7%
No 42.3% 38.3%
Hypertension 0.18
Yes 84.1% 86.3%
No 15.9% 13.7%
Dyslipidemia 0.90
Yes 25.2% 25.5%
No 74.8% 74.5%
Current smoking 0.006
Yes 6.4% 3.4%
No 93.6% 96.6%
Myocardial infarction (prior) 0.010
Yes 22.5% 17.4%
No 77.5% 82.6%
Heart failure hospitalization status 0.007
Incident 24.7% 30.6%
Recurrent 75.3% 69.4%
Renal failure 0.07
Yes 28.6% 24.7%
No 71.4% 75.3%
Ejection fraction less than 35% <0.001
Yes 82.9% 89.6%
No 17.1% 10.4%
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of men was 67.2±14.5 years. Table 1 describes the demographic
and clinical characteristics of adult men and women hospitalized
with decompensated HF in Puerto Rico during 2007 and 2009.
The proportion of older Puerto Rican women hospitalized with
decompensated HF was signiﬁcantly higher than the proportion
of their counterpart older men hospitalized with the same
condition during the study years. Women smoked approximately
half less than men, had signiﬁcantly higher proportion of
recurrent episodes of incidental hospitalizations for decompen-
sated HF and EFs less than 35%. The difference in the
proportions of common risk factors such as diabetes mellitus
and previous history of renal failure was higher among women
and borderline statistically signiﬁcant.
Table 2 describes the association between LOS and gender, as
well as other possible confounders. There were signiﬁcant
associations (P <0.05) between LOS and age, history of prior
hospitalization for HF, renal failure, and EF less than 35%. The
percentage of women hospitalized for 6 or more days was 45.1%
compared with 43.3% of men. Gender and LOS were not
signiﬁcantly associated.
Table 3 describes unadjusted and adjusted odds ratios for LOS.
No collinearity was observed in the adjusted model. Age,
diabetes, hypertension, dyslipidemia, smoking, and history of MI
were included in the adjusted model due to their clinical
importance. In the adjusted model, after controlling for all
confounders and clinically important factors, women with HF
had similar odds of extended LOS compared with men (OR 1.1;
95% CI 0.9, 1.4). The only risk factors with signiﬁcant
adjusted odds ratios were history of prior hospitalization for
HF, renal failure, and EF less than 35%. Patients with incidental
decompensated HF hospitalizations were 40% more likely to
have long hospital stays compared with patients with recurrent
decompensated HF hospitalizations (OR 1.4 (95% CI 1.1, 1.8).
Patients with renal failure and EF <35% had almost twice
the odds of extended LOS compared with patients without, with
ORs of 1.7 (95% CI 1.3, 2.1) and 2.1 (95% CI 1.5, 2.8),
respectively.
4. Discussion
While our ﬁndings did not allow us to demonstrate a
statistically signiﬁcant difference between our main indepen-
dent variable (gender) and our dependent variable (LOS)
among Puerto Ricans hospitalized with decompensated HF
during our study period, it is important to highlight that, on
average, women were 5 years older than men at admission, and
that 16% more women than men had >66 years of age, which
yielded a statistically signiﬁcant difference. Other cardiovascu-
lar risk factors such as diabetes mellitus, hypertension,
dyslipidemia, older age, smoking, and history of MI were
not associated with longer LOS. A recent publication by Chen
et al. on the national trends of HF hospital stay rates between
2001 and 2009 in the United States highlights that etiology of
HF often differs between younger and older populations:
hypertension is the most common etiology of HF in younger
adults, and as the population ages, coronary heart disease
becomes the most common factor for HF. In addition, as age
increases, the prevalence of HF with preserved EF rises
dramatically, along with hypertension, atrial ﬁbrillation,
diabetes mellitus, and renal insufﬁciency.[12] Our data show
a similar increase of the proportion of patients with decom-
pensated HF with aging of the study population in both
genders (Table 1), along with a corresponding increase in LOS
of greater than or equal to 6 days (Table 2), especially among
those ≥66 years old. Whether HF hospital stay rates differ
across age groups in the United States population is
unknown.[12]
These conclusions are similar to other studies, which found no
association between gender and LOS among HF
patients.[5,7,13,14] In contrast, two other studies concluded that
there was an association between gender and LOS among HF
patients.[6,15] This difference may be due to the factors controlled
for in those studies or due to differences in the samples under
observation. Our ﬁndings related to renal failure are similar to
those of another study that found renal failure patients were more
likely to have a longer hospital stay.[16]
4.1. Strengths and limitations
A novel aspect of this study is that it is the ﬁrst to research an
association between gender and length of hospital stay among
Puerto Rican patients. An additional strength of this study is that
each case was independently validated according to the
admission criteria for decompensated HF.
This study has at least the following limitations: Since the study
population was drawn only from Hispanic Puerto Rican patients
living in Puerto Rico, generalizability to other Hispanic
Table 2
Unadjusted association between length of stay (LOS) and risk
factors among Puerto Ricans hospitalized with decompensated
heart failure (HF) (N=1724).
Length of stay
Characteristics
Less than or
equal to 5 days
(n=963)
Greater than or
equal to 6 days
(n=761) P
Gender 0.45
Men 56.7% 43.3%
Women 54.9% 45.1%
Age 0.005
<50 59.5% 40.5%
50–65 61.5% 38.5%
≥66 53.0% 47.0%
Diabetes mellitus 0.21
Yes 54.6% 45.4%
No 57.7% 42.3%
Hypertension 0.53
Yes 55.5% 44.5%
No 57.6% 42.4%
Dyslipidemia 0.14
Yes 53.0% 47.0%
No 57.1% 42.9%
Current smoking 0.21
Yes 48.8% 51.3%
No 55.9% 44.1%
Myocardial infarction (prior) 0.49
Yes 57.7% 42.3%
No 55.6% 44.4%
Heart failure hospitalization status <0.001
Incident 48.0% 52.0%
Recurrent 58.9% 41.1%
Renal failure <0.001
Yes 47.2% 52.8%
No 59.0% 41.0%
Ejection fraction less than 35% <0.001
Yes 45.4% 54.6%
No 57.5% 42.5%
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populations in the United States should be done with caution. In
addition, the nature of the secondary data analysis introduced
limitations to the study design. More than 40% of patients had
missing information related to type of ventricular failure, type of
dysfunction, and speciﬁc data related to EF, so these factors were
excluded from analysis. Residual congestion is a condition that
needs to be indispensably assessed in patients hospitalized with a
decompensated HF condition before the patient’s discharge.
The decision to discharge a patient should be based on at
least 3 assessment tools available in clinical practice: clinical
condition,[17] such as persistent of dyspnea/shortness of breath
and fatigue; biological measures,[18] such as hemoconcentration,
worsening of renal function, absence of weight loss, and
reduction of peripheral edema; and worsening of signs of
persistent heart and lung congestion obtained by imaging
tools,[19] such as X-rays or ultrasounds. Results of this assessment
provide a key prognostic indicator that impacts the clinician’s
decision to discharge a patient, and thus, their LOS. Unfortu-
nately, the PRCVSS study does not collect information on
residual congestion per se, or on the risk assessment that
clinicians use to discharge a patient.
In conclusion, there was no association between the gender of
adult Puerto RicanHF patients and their length of hospital stay in
2007 and 2009. The fact that older women hospitalized with an
incidental episode of decompensated HF and with a positive
previous history of renal failure and EF less than 35% have a
signiﬁcantly higher likelihood of staying ≥6 days represent a
health care disparity and may have at least 3 major clinical
implications: First, individuals with these clinical characteristics
who do not receive opportune diagnosis and evidence-based
health care management may unnecessarily increase the overall
costs of health care. Second, the extended hospitalization
stay may also worsen the prognosis of patients exposing
this group of patients to potential iatrogenic infections and
premature death. And third, this may represent a missing
opportunity for health care providers working in Puerto Rico to
improve health care disparities for older high risk women
hospitalized with decompensated HF. Future studies should have
a prospective design and may include more detailed information
related to type of HF and type of dysfunction, as well as
information on residual congestion and risk assessment before
patient’s discharge.
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